Novoeight is used in patients with hemophilia A after trauma or surgery. As a man-made form of clotting factor VIII, Novoeight works to stop bleeding.

Xyntha Vial is a man-made form of clotting factor VIII. Xyntha Vial is used to control and prevent bleeding episodes in hemophilia A patients with low factor VIII levels.

Wilate Vial contains man-made clotting factors including von Willebrand factor (WWF) and clotting factor VIII. Wilate Vial is indicated to temporarily replace the deficiency of clotting factors and reduce bleeding in patients with inherited blood clotting disorders such as von Willebrand disease, hemophilia A, ...